Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lukusa AK et al. - With regard to HU, semen impairment appears to be related to the duration of treatment. To draw general conclusions, further research with a large number of patients treated since childhood with HU or HSCT is warranted.


Today in Anemia/Polycythemia...keeping you current

A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases
World Journal of Gastroenterology, 10/12/09

Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09

Sickle cell disease and stroke
Blood, 10/13/09

Today in BMT/SCT...keeping you current

5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
Bone Marrow Transplantation, 10/15/09

Management of relapse after allo-SCT for AML and the role of second transplantation
Bone Marrow Transplantation, 10/29/09

New advances in the treatment of acute promyelocytic leukemia
International Journal of Hematology, 10/07/09

Today in Coagulation/Bleeding Dz...keeping you current

Management of the antiphospholipid syndrome: new approaches
International Journal of Clinical Rheumatology, 10/19/09

Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Annals of Hematology, 10/23/09

Sickle cell disease and stroke
Blood, 10/13/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address